Contact
News

Latest Press Releases

View More
Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
November 6, 2025

Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.

Latest Publications

View More
Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
November 6, 2025

Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.

Where science meets health: intelligent anti-inflammation to accelerate therapies for obesity & CKD.

Linkedin-in X-twitter

01

About Us

02

Our Approach

03

Our Team

04

Pipeline

05

News
Address

8 THE GREEN, SUITE 8235 DOVER DE 19901

Contact

Info@mwyngil.com